Michael Faerm was named Chief Financial Officer of AtaiBeckley Inc. As of November 14, 2026, AtaiBeckley Inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from January 8, 2026 to September 11, 2026, naming 2 appointments (Form 8-K, February 19, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like AtaiBeckley Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-09-11
- · In / out: In · Person: Michael Faerm · Role: Chief Financial Officer · 8-K, 2026-02-19
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-01-08
AtaiBeckley Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-08 to 2026-09-11. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as AtaiBeckley Inc. files it.
Also on the record for AtaiBeckley Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 14, 2026 | Stake report, Schedule 13D/A, by Apeiron Investment Group Ltd. | — | 5%+ stakes | Source |
| September 11, 2026 | Acquired by Eli Lilly and Company | — | Acquisition | Source |
| July 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 6.8% of the class | 5%+ stakes | Source |
| July 17, 2026 | Stake report, Schedule 13D/A, by Apeiron Investment Group Ltd. | 15.4% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs AtaiBeckley Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on AtaiBeckley Inc. and the records around it.
AtaiBeckley Inc. elsewhere on the record
- 5%+ stake filings Sep 2026
- Acquisition Sep 2026
Companies that share a holder
- Apeiron Investment Group Ltd. also filed stake reports on 2 other companies: Enhanced Group Inc. (Nov 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch AtaiBeckley Inc.
Get an email when AtaiBeckley Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on AtaiBeckley Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on AtaiBeckley Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AtaiBeckley Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-11 | Reported | not named in the filing | 8-K, 2026-09-11 | ||
| 2026-02-19 | In | Chief Financial Officer | 8-K, 2026-02-19 | ||
| 2026-02-19 | In | 8-K, 2026-02-19 | |||
| 2026-01-08 | Reported | not named in the filing | 8-K, 2026-01-08 |
Who leads AtaiBeckley Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Michael Faerm, appointed (filed 2026-02-19).
New leaders reset buying decisions — get the Full Report on AtaiBeckley Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at AtaiBeckley Inc., with the record behind each one.
Find candidates like Chief Financial Officer at AtaiBeckley Inc.Every change, in the filing's words
Reported
In accordance with the terms of the Merger Agreement, at the Effective Time, each of the members of the Company's Board of Directors, each of whom was a director of the Company as of immediately prior to the Effective Time, resigned and ceased to be a director of the Company and a member of any committee of the Company's Board of Directors.
- In accordance with the terms of the Merger Agreement, at the Effective Time, Christopher Anderson and Jonathan R. Haug, the directors of Merger Sub immediately prior to the Effective Time, became directors of the Company.
- In accordance with the terms of the Merger Agreement, at the Effective Time, each of the executive officers of the Company resigned from their positions as officers of the Company.
- In accordance with the terms of the Merger Agreement, at the Effective Time, the officers of Merger Sub immediately prior to the Effective Time, Jonathan R. Haug as President, Steffanie Lim-Ho as Treasurer, Christopher Anderson as Secretary, Jonathan Groff as Assistant Secretary, Jamie Burnett as Assistant Secretary and Katie Lodato as Assistant Treasurer, became the officers of the Company.
- On September 10, 2026, the Board of Directors of the Company approved the grant of a retention bonus to Gerd Kochendoerfer in the amount of $194,000, less applicable deductions and withholdings.
- Subject to Mr. Kochendoerfer's continued employment with the Company through the Effective Time, the retention bonus will be paid to him on the first regularly scheduled payroll date following the Closing Date that is at least 10 days after the Closing Date.
Appointed: Michael Faerm, Chief Financial Officer
On February 15, 2026, the Board of Directors of AtaiBeckley Inc. (the "Company") appointed Michael Faerm as the Company's Chief Financial Officer, effective as of the date Mr. Faerm commences employment with ATAI Life Sciences US, Inc. ("ATAI US"), which is expected to occur on March 9, 2026 (the "Appointment Date").
Appointed: Michael Faerm
In connection with his appointment, effective as of the Appointment Date, Mr. Faerm has been designated as the Company's principal financial officer.
- Mr. Faerm succeeds Anne Johnson, who will cease serving as Chief Financial Officer, and will serve as the Company's Chief Accounting Officer and remain designated as the Company's principal accounting officer, in each case effective as of the Appointment Date.
- Michael Faerm, 59, most recently served as a consulting Chief Financial Officer to various biopharmaceutical companies through his firm, MEF Consulting LLC, from February 2025 to February 2026.
- From May 2024 to February 2025, Mr. Faerm served as Chief Financial Officer of Viracta Therapeutics, Inc., a precision oncology company.
- From October 2023 to March 2024, Mr. Faerm served as Interim Chief Financial Officer of Harpoon Therapeutics, Inc., an immunotherapy company.
- From April 2021 to March 2023, Mr. Faerm served as Chief Financial Officer of Artiva Biotherapeutics, Inc., a natural killer (NK) cell-based therapy company.
- From 2019 to 2021, Mr. Faerm served as a consulting and interim Chief Financial Officer and Chief Business Officer to various biopharmaceutical companies through his firm, MEF Consulting LLC.
Reported
On January 6, 2026, Cosmo Feilding-Mellen resigned from the board of directors (the "Board") of AtaiBeckley Inc. (the "Company"), effective immediately.
- Mr. Feilding-Mellen's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies and practices.
Tools for this story
Each opens in a new tab, filled in for AtaiBeckley Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
